Aarti Pharmalabs Ltd. - Research Center
543748 AARTIPHARM Group (A) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Sales |
414.82 |
373.03 |
356.14 |
358.14 |
374.27 |
Operating profit |
107.33 |
88.27 |
73.81 |
76.74 |
76.79 |
Interest |
4.42 |
4.10 |
3.82 |
4.03 |
5.80 |
Gross profit |
108.60 |
84.37 |
69.99 |
77.57 |
70.99 |
EPS (Rs) |
6.95 |
5.32 |
4.61 |
5.26 |
4.41 |
Quarterly
results in details
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Other income |
5.69 |
0.20 |
- |
4.86 |
- |
Stock adjustment |
7.36 |
-5.32 |
-6.11 |
-19.29 |
-8.70 |
Raw material |
179.69 |
191.11 |
196.88 |
193.64 |
210.12 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
34.67 |
34.29 |
29.84 |
31.53 |
30.94 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
85.77 |
64.68 |
61.72 |
75.52 |
65.12 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
17.32 |
16.94 |
16.32 |
15.44 |
14.25 |
Taxation |
28.26 |
19.25 |
11.86 |
14.50 |
16.75 |
Net profit / loss |
63.02 |
48.19 |
41.81 |
47.63 |
39.99 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
45.31 |
45.31 |
45.31 |
45.31 |
45.31 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
25.87 |
23.66 |
20.72 |
21.43 |
20.52 |
GPM (%) |
25.83 |
22.61 |
- |
21.37 |
- |
NPM (%) |
14.99 |
12.91 |
- |
13.12 |
- |